Signal Genetics' IPO

Signal Genetics raised a round of funding on June 18, 2014. Investors include Public.

Signal Genetics (NASDAQ: SGNL) is a commercial stage, molecular diagnostic company focused on providing innovative diagnostic services that help physicians make better-informed decisions concerning th…

Articles about Signal Genetics' IPO: